News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
173,662 Results
Type
Article (15063)
Company Profile (20)
Press Release (158577)
Multimedia
Podcasts (7)
Webinars (3)
Section
Business (48830)
Career Advice (224)
Deals (6068)
Drug Delivery (23)
Drug Development (20501)
Employer Resources (25)
FDA (3336)
Job Trends (3824)
News (73515)
Policy (6099)
Tag
2027 BioCapital Standard (1)
2027 Biotech Bay Elite (1)
Academia (1745)
Accelerated approval (12)
ADA (16)
Adcomms (13)
Allergies (35)
Alliances (13643)
ALS (85)
Alzheimer's disease (670)
Antibody-drug conjugate (ADC) (110)
Approvals (3502)
Artificial intelligence (214)
ASCO (108)
Autoimmune disease (58)
Automation (11)
Bankruptcy (42)
Best Places to Work (3280)
BIO (17)
Biologics (1)
BIOSECURE Act (14)
Biosimilars (31)
BioSpace Insights (27)
Biotechnology (18)
Bladder cancer (86)
Brain cancer (33)
Breast cancer (290)
Cancer (2196)
Cardiovascular disease (109)
Career advice (216)
Career pathing (5)
CAR-T (119)
CDC (22)
CDMO (23)
Cell therapy (266)
Cervical cancer (19)
Clinical research (17321)
Collaboration (617)
Commercialization (2)
Company closure (2)
Compensation (51)
Complete response letters (8)
COVID-19 (1092)
CRISPR (36)
C-suite (313)
Cystic fibrosis (35)
Data (2344)
Decentralized trials (1)
Denatured (1)
Depression (40)
Dermatology (20)
Diabetes (142)
Diagnostics (1963)
Digital health (14)
Diversity (3)
Diversity, equity & inclusion (9)
Drug discovery (104)
Drug pricing (34)
Drug shortages (3)
Duchenne muscular dystrophy (43)
Earnings (11477)
Editorial (17)
Employer branding (3)
Employer resources (23)
Events (25417)
Executive appointments (259)
FDA (4255)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (11)
Frontotemporal dementia (18)
Funding (745)
Gene editing (66)
Generative AI (8)
Gene therapy (221)
GLP-1 (154)
Government (1331)
Grass and pollen (1)
Guidances (90)
Healthcare (5353)
Hematology (62)
HIV (30)
Huntington's disease (7)
IgA nephropathy (11)
Immunology and inflammation (37)
Immuno-oncology (36)
Indications (47)
Infectious disease (1194)
Inflammatory bowel disease (61)
Inflation Reduction Act (2)
Influenza (26)
Intellectual property (56)
Interviews (21)
IPO (2984)
IRA (15)
Job creations (623)
Job search strategy (199)
JPM (3)
Kidney cancer (11)
Labor market (27)
Layoffs (76)
Leadership (3)
Legal (1153)
Licensing (4)
Liver cancer (29)
Longevity (11)
Lung cancer (258)
Lymphoma (175)
Machine learning (18)
Management (7)
Manufacturing (196)
Marketing (5)
MASH (43)
Medical device (2918)
Medtech (2950)
Mergers & acquisitions (3441)
Metabolic disorders (249)
mRNA (44)
Multiple sclerosis (51)
NASH (4)
Neurodegenerative disease (131)
Neuropsychiatric disorders (15)
Neuroscience (1154)
NextGen: Class of 2026 (1817)
Non-profit (2112)
Now hiring (9)
Obesity (68)
Opinion (73)
Ovarian cancer (83)
Pain (73)
Pancreatic cancer (135)
Parkinson's disease (114)
Partnered (11)
Patents (108)
Patient recruitment (206)
Peanut (14)
People (17467)
Pharmaceutical (6)
Pharmacy benefit managers (2)
Phase 1 (5705)
Phase 2 (7837)
Phase 3 (5370)
Pipeline (2497)
Policy (101)
Postmarket research (636)
Preclinical (2568)
Press Release (18)
Prostate cancer (110)
Psychedelics (16)
Radiopharmaceuticals (79)
Rare diseases (247)
Real estate (1386)
Recruiting (13)
Regulatory (4901)
Reports (14)
Research institute (2015)
Resumes & cover letters (18)
Rett syndrome (3)
RNA editing (3)
RSV (12)
Schizophrenia (55)
Series A (97)
Series B (58)
Sickle cell disease (33)
Special edition (1)
Spinal muscular atrophy (38)
Sponsored (4)
Startups (1145)
Stomach cancer (3)
Supply chain (27)
Tariffs (12)
The Weekly (6)
Vaccines (355)
Venture capital (37)
Weight loss (28)
Women's health (31)
Worklife (4)
Date
Today (9)
Last 7 days (97)
Last 30 days (507)
Last 365 days (6466)
2026 (4321)
2025 (6629)
2024 (7954)
2023 (9470)
2022 (13126)
2021 (14193)
2020 (13456)
2019 (12268)
2018 (9154)
2017 (8048)
2016 (8479)
2015 (10041)
2014 (7522)
2013 (6306)
2012 (6358)
2011 (6524)
2010 (5454)
Location
Africa (207)
Alabama (69)
Alaska (3)
Arizona (106)
Arkansas (4)
Asia (10180)
Australia (2250)
California (2989)
Canada (772)
China (284)
Colorado (153)
Connecticut (122)
Delaware (140)
Europe (22465)
Florida (575)
Georgia (87)
Idaho (14)
Illinois (280)
India (24)
Indiana (109)
Iowa (8)
Japan (170)
Kansas (28)
Kentucky (27)
Louisiana (48)
Maine (14)
Maryland (382)
Massachusetts (1947)
Michigan (51)
Minnesota (162)
Mississippi (1)
Missouri (57)
Montana (7)
Nebraska (5)
Nevada (73)
New Hampshire (20)
New Jersey (1115)
New Mexico (8)
New York (1025)
North Carolina (344)
North Dakota (4)
Northern California (1454)
Ohio (122)
Oklahoma (9)
Oregon (10)
Pennsylvania (585)
Puerto Rico (4)
Rhode Island (14)
South America (290)
South Carolina (19)
Southern California (1208)
Tennessee (74)
Texas (657)
United States (11527)
Utah (88)
Vermont (1)
Virginia (83)
Washington D.C. (39)
Washington State (299)
West Virginia (2)
Wisconsin (38)
173,662 Results for "la jolla institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
La Jolla Labs Inc., Unravel Biosciences Inc., and Ulm University Announce Strategic Collaboration to Advance AI-Driven Therapeutics for ALS
July 16, 2026
·
1 min read
Press Releases
La Jolla Labs, Inc. Announces First Patient Treated with Custom Antisense Therapy GBFsen for familial ALS
April 30, 2026
·
1 min read
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases.
April 18, 2024
·
2 min read
Press Releases
La Roche-Posay Announces 2025 Young Investigator Grant Winners and Opens Applications for 2026 Program
August 17, 2026
·
3 min read
Press Releases
Precipio to Present at the Planet MicroCap Las Vegas
June 12, 2026
·
5 min read
Press Releases
SoCalBio Unveils New Brand Reflecting Greater LA’s Growth as a Global Bioscience Hub
June 23, 2026
·
4 min read
Press Releases
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
June 10, 2026
·
1 min read
Press Releases
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
June 11, 2026
·
1 min read
Press Releases
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference
June 11, 2026
·
2 min read
Job Trends
The Next Cambridge? LA Sets Its Sights Higher
The Los Angeles region is one of California’s fastest-growing life sciences hubs, according to a California Life Sciences sector report. The CEO of BioscienceLA discusses the market’s strengths, challenges and where it might be five years from now.
March 12, 2026
·
5 min read
·
Angela Gabriel
1 of 17,367
Next
